PARLIAMENTARY WRITTEN QUESTION
Tixagevimab/cilgavimab (14 June 2022)
Question Asked
To ask the Secretary of State for Health and Social Care, when the results of testing by the UKHSA on Evusheld’s effectiveness against the Omicron variant will be published.
Asked by:
Feryal Clark (Labour)
Asked by:
Feryal Clark (Labour)
Answer
AstraZeneca commissioned the UK Health Strategic Authority to undertake testing into the effectiveness on Evusheld against the Omicron variants. Initial data has been shared with AstraZeneca.
The Department is assessing of Evusheld, which includes requesting clinicians to advise on the most appropriate option for the National Health Service in line with available data, the public health situation and alongside other treatments available. As we are currently considering this advice, we are unable to confirm a specific timetable for the decision.
Answered by:
Maggie Throup (Conservative)
4 July 2022
Contains Parliamentary information licensed under the Open Parliament Licence v3.0.